Canonical microRNA loss drives tumor development implicating therapeutic efficacy of enoxacin in angiosarcoma
Murphy, A.; Liu, B.; Benton, A.; Gartenhaus, L.; Hartzler, S.; Yates, M. E.; Alzate, A. R.; Janson, N. D.; Jayasundara, S.; Utturkar, S.; Lanman, N. A.; Kazemian, M.; Hanna, J. A.
Show abstract
Angiosarcoma (AS) is a rare and aggressive tumor arising within the endothelium, characterized by a high metastatic rate and poor prognosis. Our prior work established that endothelial loss of Dicer1, a key enzyme in microRNA (miRNA) processing, drives AS formation in mice, indicating a tumor suppressive role for miRNAs in tumorigenesis. Here, we corroborated this hypothesis by generating a novel conditional knockout model targeting Dgcr8, a core component of the microprocessor complex required for pri-miRNA processing. Conditional deletion of Dgcr8 phenocopies Dicer1 loss, resulting in spontaneous AS formation and global loss of mature miRNAs. We further demonstrate that treatment with enoxacin (ENX), a repurposed antibiotic known to enhance miRNA processing, reduces viability, migration, and clonogenicity of AS cells. ENX increases the abundance of tumor-suppressive miRNAs and downregulates oncogenic pathways, including pathways related to cell cycle progression, angiogenesis, and cell migration. These results establish the essential role of miRNA biogenesis in suppressing AS and reveal a pharmacologically targetable vulnerability via ENX-mediated enhancement of miRNA expression in tumors.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma 95%
- Combining Plasma Extracellular Vesicle Let-7b-5p, miR-184 and Circulating miR-22-3p Levels for NSCLC Diagnosis and Drug Resistance Prediction 94%
- Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indications in a common base culture media system 94%
Similar papers in this journal
- Melanoblast transcriptome analysis reveals novel pathways promoting melanoma metastasis 95%
- GLUT1 inhibition blocks growth of RB1-positive Triple Negative Breast Cancer 95%
- Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma 95%
Similar papers in this journal
- The epithelial-mesenchymal transcription factor SNAI1 represses transcription of the tumor suppressor miRNA let-7 in cancer 96%
- Propagated circulating tumor cells uncovers the rople of NFκB and COP1 in metastasis 95%
- Genome-wide CRISPR screen identifies KEAP1 perturbation as a vulnerability of ARID1A-deficient cells 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.